Medicinal product name DuoResp Spiromax
Pharmaceutical form Inhalation powder
Strength 160 μg/4.5 μg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/14/920/001 KZSL1N120 Is available
Legal status Rx Prescription (Pr.)
KZSL1 Next lowest cost medicine
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code R03AK07 Drugs for obstructive airway diseases

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(304 containers)
Tamro, Olainfarm, Magnum Medical N120
(160 µg/4,5 µg)
Inhaler 56.50 
KZSL1*
EU/1/14/920/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/14/920/001
Date of authorisation Apr 28, 2014
Marketing authorisation holder, country Teva Pharma B.V., Netherlands